USP39 and central nervous system cancer: USP39 protein levels were increased in high-grade glioma samples (WHO III–IV; n = 8) relative to low-grade glioma (WHO II; n = 4) and nonneoplastic human brain tissue samples (n = 3; Fig. 1c).